Financials
- Market Capitalization 263.9 M
- Employee 44
- Founded 2015
- CEO N/A
- Website www.surrozen.com
- Headquarter Delaware, United States
- FIGI BBG00XY94S95
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.7
Relación precio/flujo de caja
0.05
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3417 | NAGE Niagen Bioscience, Inc. - Common Stock | 3.31 USD | -4.61% | -7.28% | -4.89% | -33.53% | 263.62 M USD | ||
| 3432 | ALXO ALX Oncology Holdings Inc. - Common Stock | 1.93 USD | -2.03% | -18.57% | +21.38% | +319.57% | 259.71 M USD | ||
| 3455 | RNAC Cartesian Therapeutics, Inc. - Common Stock | 8.77 USD | +1.62% | -13.94% | -9.49% | -4.26% | 257.68 M USD | ||
| 3470 | TRDA Entrada Therapeutics, Inc. - Common Stock | 6.60 USD | 0.00% | -12.12% | +0.15% | -5.31% | 256.22 M USD |